This Analyst Cut Price Target On Canopy Growth After Q1 Earnings Release, Here's Why

On Friday, Canopy Growth Corporation CGC reported a 19% year-over-year drop in net revenue to CA$110 million ($112.2 million) n the first quarter of fiscal 2023.

However, its international medical cannabis net revenue approximately doubled over the same period, driven primarily by strong sales in Israel and Australia. The Canadian cannabis giant is optimistic about the export outlook, given the 30% quarter-over-quarter shipment increase to the two countries.

Canopy’s management is confident that recent cost cuts will result in positive EBITDA by fiscal 2024, Cantor Fitzgerald’s analyst Pablo Zuanic said in his recent note. For the first quarter, adjusted EBITDA came in negative at CA$75 million. 

The Analyst

Zuanic retained a Neutral rating on the stock while cutting his price target to CA$3.70 from CA$3.75 due to the stock/sector derating and reduced estimates.

The Thesis

The analyst also pointed out that the company reported a free cash outflow of CA$143 million in the first three months of the fiscal year, while the net debt nearly doubled, reaching CA$241 million by the end of June when it acquired approximately CA$$263 million of convertible notes from Constellation Brands, Inc. STZ by issuing roughly 77 million shares.

“Even with those actions, at the current burn rate, we think net debt could be 1x by June next year (with the STZ held warrants out of the money, we assume other potentially dilutive actions could be needed),” Zuanic said.

CGC Price Action

Canopy’s shares traded 7.79% lower at $2.665 per share at the time of writing on Friday.

Benzinga Cannabis Capital Conference

Come and meet Pablo Zuanic in person at the Benzinga Cannabis Capital Conference on September 13-14 in Chicago. 

Get your conference tickets HERE. Book your room in the historic Palmer House Hotel HERE.  See you in Chicago!

sept_2022_ccc_1200x800_2_0.png

 

Photo: Courtesy of gerald by Pixabay

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: Analyst ColorCannabisEarningsNewsPenny StocksSmall CapMarketsCantor Fitzgeraldfirst quarter earningsmarijuanaPablo Zuanicstock analysis
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!
CCC-Oct-24-Banner-1

Click on the image for more info.

Cannabis rescheduling seems to be right around the corner

Want to understand what this means for the future of the industry?

Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. 

Get your tickets now before prices surge by following this link.